• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

GSK, after consumer spinoff, touts momentum for core products Cabenuva and Shingrix

cafead

Administrator
Staff member
  • cafead   Feb 01, 2023 at 11:12: AM
via With GSK’s consumer healthcare spinoff now in the rearview mirror, the company is operating as the lean, innovative medicines-focused drugmaker CEO Emma Walmsley envisioned years ago (PDF).

And 2022’s financial performance shows the company’s promise as it seeks to grow sales by at least 5% annually through 2026.

article source
 

<